Latest News
-
TOKYO & NEW YORK – Eisai Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) announced that the companies have entered into an exclusive global strategic collaboration agreement for the co-development and co-commercialization of MORAb-202, an antibody drug conjugate (ADC). MORAb-202 is Eisai’s first ADC and combines Eisai’s in house developed... -
DUBLIN – Horizon Therapeutics plc (Nasdaq: HZNP) announced that it has reached an agreement to purchase a drug product manufacturing facility from EirGen Pharma, an OPKO Health Company (Nasdaq: OPK) in Waterford, Ireland. The facility, which is located in an IDA Ireland business park, includes a filling line and lyophiliser,...
-
BETHESDA, Md. – The Cystic Fibrosis Foundation affirmed its support for the PASTEUR Act, a bipartisan proposal that, if passed, will support the development of new antibiotics and promote appropriate use of existing ones. The organization issued the following statement: “New solutions are needed now to bring novel antibiotics into...
Videos
Rare disease spotlight
@KathyConWom Whether they are vaccinated or not they can still catch and spread the virus. So why are they so desperate to vaccinate everyone ?
@JuliaHB1 The secret to stop this madness is STOP getting tested, you only fuelling numbers and causing restrictions. Feel ok? Live your life. Not feeling ok? Stay home till you get better. Don’t need a test to tell you that you’re sick!
